Literature DB >> 622216

Augmenting/reducing: an adaptive switch mechanism to cope with incoming signals in healthy subjects and psychiatric patients.

L von Knorring, K Monakhov, C Perris.   

Abstract

The tendency to 'augment' or to 'reduce' the amplitude of the response to stimuli of increasing intensity is a matter of much interest in the neurophysiological, psychophysiological and psychiatric literature. According to their response, individuals have been divided so far into 'augmenters' and 'reducers', and different mechanisms beyond these types of response have been discussed. In most studies, however, the major emphasis has been laid upon 'reducing', which has been regarded as deviance from the expected 'augmenting'. In the present article, a new theory referring to a two-directional adaptive switch mechanism for coping with incoming stimuli is presented together with some hypotheses which can be derived from such a general theory. In the following, evidence from experimental work is presented which supports the main theoretical principles, and also the hypothesis that both basic characteristics of the central nervous system and biochemical variables contribute to the determination of the individual augmenting/reducing response.

Entities:  

Mesh:

Year:  1978        PMID: 622216     DOI: 10.1159/000117630

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

1.  Brief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment.

Authors:  J Martineau; C Barthelemy; C Cheliakine; G Lelord
Journal:  J Autism Dev Disord       Date:  1988-09

2.  Neurobiological approaches in human behavior genetics.

Authors:  F Vogel
Journal:  Behav Genet       Date:  1981-03       Impact factor: 2.805

3.  Disturbance of serotonergic neurotransmission in patients with postmyocardial infarction and depression.

Authors:  Gabriel Manjarrez-Gutiérrez; Rodolfo Ramírez-Campillo; Gabriela Borrayo-Sánchez; Jorge Hernández-Rodríguez
Journal:  Metab Brain Dis       Date:  2012-11-06       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.